MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2022 Sep 15

PMID 36105241

Authors

Wei Zhang

Xinghong Huang

Rong Huang

Hong Zhu

Pu Ye

Xuyang Lin

Shuangyue Zhang

Meng Wu

Feng Jiang

Affiliations

Soon will be listed here.

Abstract

Matrix metalloproteinase-1 (MMP1) has been reported to play key roles in a variety of cancers by degrading the extracellular matrix. However, its carcinogenic roles have not been shown yet in head and neck squamous cell carcinoma (HNSCC). This study aimed to elucidate its expression pattern and functional roles as well as clinical significance in HNSCC. The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and immunohistochemistry (IHC) were utilized to determine the MMP1 expression pattern and the associations between its expression and patients' outcome in HNSCC. Mice tongue squamous cell carcinoma model induced by 4-nitroquinoline 1-oxide (4NQO) and siRNA-mediated cellular assay in vitro were utilized to evaluate the oncogenic role of MMP1. The biological functions and cancer-related pathways involved in MMP1-related genes were found through bioinformatics analysis. Both mRNA and protein abundance of MMP1 were highly increased in HNSCC as compared to its non-tumor counterparts. MMP1 overexpression positively correlated with advanced tumor size, cervical node metastasis, and advanced pathological grade and lower patients' survival. In the 4NQO-induced animal model, MMP1 expression increased along with the progression of the disease. In HNSCC cells, siRNA-mediated knockdown of MMP1 significantly inhibited cell proliferation, migration, and invasion and activated apoptosis and epithelia-mesenchymal transition (EMT). GSEA, GO, and KEGG analyses showed that MMP1 expression was significantly related to cancer-related pathways and cancer-related functions. Together, our results demonstrated MMP1 serves as a novel prognostic biomarker and putative oncogene in HNSCC.

Citing Articles

Activating transcription factor 3 induces oxidative stress and genotoxicity, transcriptionally modulating metastasis-related gene expression in human papillomavirus-infected cervical cancer.

Naderzadeh E, Kargar M, Mokhtari M, Farhadi A Virol J. 2025; 22(1):46.

PMID: 39994644 PMC: 11849226. DOI: 10.1186/s12985-025-02675-0.

Development and validation of a biomarker-based prediction model for metastasis in patients with colorectal cancer: Application of machine learning algorithms.

Ayubi E, Farashi S, Tapak L, Afshar S Heliyon. 2025; 11(1):e41443.

PMID: 39839508 PMC: 11748706. DOI: 10.1016/j.heliyon.2024.e41443.

Biological implications of decoding the extracellular matrix of vulva cancer.

Islam M, Debnath K, Moniruzzaman R, Okuyama K, Islam S, Dongre H Oncol Rep. 2024; 53(2).

PMID: 39670289 PMC: 11652961. DOI: 10.3892/or.2024.8852.

SPHK1 promotes HNSCC immune evasion by regulating the MMP1-PD-L1 axis.

Fang Q, Chen X, Cao F, Xu P, Zhao Z, Lin R Theranostics. 2024; 14(18):7199-7218.

PMID: 39629135 PMC: 11610131. DOI: 10.7150/thno.102390.

Unveiling Biomarkers in Head and Neck Squamous Cell Carcinoma through Bioinformatics: The Role of and .

Cheon J, Kim B, Park J, Shin J, Kim T Int J Mol Sci. 2024; 25(22).

PMID: 39596132 PMC: 11594244. DOI: 10.3390/ijms252212062.

References

Song L, Liu H, Liu Q . Matrix metalloproteinase 1 promotes tumorigenesis and inhibits the sensitivity to 5-fluorouracil of nasopharyngeal carcinoma. Biomed Pharmacother. 2019; 118:109120. DOI: 10.1016/j.biopha.2019.109120. View

Jonsson A, Falk P, Angenete E, Hjalmarsson C, Ivarsson M . Plasma MMP-1 Expression as a Prognostic Factor in Colon Cancer. J Surg Res. 2021; 266:254-260. DOI: 10.1016/j.jss.2021.04.021. View

Johnson D, Burtness B, Leemans C, Lui V, Bauman J, Grandis J . Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020; 6(1):92. PMC: 7944998. DOI: 10.1038/s41572-020-00224-3. View

Shen C, Kuo Y, Chen C, Chen M, Cheng Y . MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer. PLoS One. 2017; 12(3):e0174487. PMC: 5363985. DOI: 10.1371/journal.pone.0174487. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

Bakir B, Chiarella A, Pitarresi J, Rustgi A . EMT, MET, Plasticity, and Tumor Metastasis. Trends Cell Biol. 2020; 30(10):764-776. PMC: 7647095. DOI: 10.1016/j.tcb.2020.07.003. View

Van Doren S . Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol. 2015; 44-46:224-31. PMC: 4466143. DOI: 10.1016/j.matbio.2015.01.005. View

Denaro N, Russi E, Merlano M . Pros and Cons of the New Edition of TNM Classification of Head and Neck Squamous Cell Carcinoma. Oncology. 2018; 95(4):202-210. DOI: 10.1159/000490415. View

Yu J, Xu Z, Guo J, Yang K, Zheng J, Sun X . Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting role. Cell Death Discov. 2021; 7(1):343. PMC: 8578434. DOI: 10.1038/s41420-021-00730-7. View

10.

Wang Q, Lv L, Tang Y, Zhang L, Wang L . MMP-1 is overexpressed in triple-negative breast cancer tissues and the knockdown of MMP-1 expression inhibits tumor cell malignant behaviors . Oncol Lett. 2019; 17(2):1732-1740. PMC: 6341686. DOI: 10.3892/ol.2018.9779. View

11.

Tan T, Miow Q, Miki Y, Noda T, Mori S, Huang R . Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014; 6(10):1279-93. PMC: 4287932. DOI: 10.15252/emmm.201404208. View

12.

Zhang W, Huang X, Huang R, Zhu H, Ye P, Lin X . MMP1 Overexpression Promotes Cancer Progression and Associates with Poor Outcome in Head and Neck Carcinoma. Comput Math Methods Med. 2022; 2022:3058342. PMC: 9467809. DOI: 10.1155/2022/3058342. View

13.

Zhao S, Yu M . Identification of as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Cervical Squamous Cell Carcinoma. DNA Cell Biol. 2020; 39(2):255-272. DOI: 10.1089/dna.2019.5129. View

14.

Wang C, Mao C, Lai Y, Cai Z, Chen W . MMP1 3'UTR facilitates the proliferation and migration of human oral squamous cell carcinoma by sponging miR-188-5p to up-regulate SOX4 and CDK4. Mol Cell Biochem. 2020; 476(2):785-796. DOI: 10.1007/s11010-020-03944-y. View

15.

Zhang W, Li J, Wu Y, Ge H, Song Y, Wang D . TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma. Cancer Cell Int. 2018; 18:178. PMC: 6233371. DOI: 10.1186/s12935-018-0675-z. View

16.

Kidacki M, Lehman H, Green M, Warrick J, Stairs D . p120-Catenin Downregulation and Mutations Cooperate to Induce Invasion through MMP1 in HNSCC. Mol Cancer Res. 2017; 15(10):1398-1409. DOI: 10.1158/1541-7786.MCR-17-0108. View

17.

Yadav L, Puri N, Rastogi V, Satpute P, Ahmad R, Kaur G . Matrix metalloproteinases and cancer - roles in threat and therapy. Asian Pac J Cancer Prev. 2014; 15(3):1085-91. DOI: 10.7314/apjcp.2014.15.3.1085. View

18.

Kitamura N, Sento S, Yoshizawa Y, Sasabe E, Kudo Y, Yamamoto T . Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci. 2021; 22(1). PMC: 7795499. DOI: 10.3390/ijms22010240. View

19.

Pastushenko I, Blanpain C . EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2018; 29(3):212-226. DOI: 10.1016/j.tcb.2018.12.001. View

20.

Bendardaf R, Buhmeida A, Ristamaki R, Syrjanen K, Pyrhonen S . MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases. Scand J Gastroenterol. 2007; 42(12):1473-8. DOI: 10.1080/00365520701485449. View